Avalo Therapeutics to Participate in Upcoming Investor Conferences

Avalo Therapeutics to Participate in Upcoming Investor Conferences GlobeNewswire May 27, 2025 WAYNE, Pa. and ROCKVILLE, Md., May 27, 2025 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused on the treatment of immune dysregulation, today announced that management will participate in the following investor conferences in June. Jefferies Global […]

Simon Quick Advisors Acquires Proquility Private Wealth Partners To Drive Purposeful, Values-Led Growth

Strategic partnership expands Simon Quick's national footprint and enriches planning-led wealth advisory services with the addition of a talented team Simon Quick Advisors, a national independent wealth management and multi-family office firm, today announced its acquisition of Las Vegas-based Proquility Private Wealth Partners, a boutique advisory firm with deep client relationships across the country and

Life365 Appoints Healthcare Veteran Jay Roberts as Chief Development Officer

Industry Leader with 30+ Years of Experience Will Drive Strategic Growth and Partnerships Life365, a leading data engagement and virtual care company, today announced the appointment of healthcare executive and investor Jay Roberts as chief development officer. https://mma.prnewswire.com/media/2695368/Life365_logo_hires.jpg Roberts, whopreviously served as an executive advisor toLife365, brings more than 30 years of strategic healthcare leadership

New Strategic Partnership Between ConnectureDRX and EvolveNXT Unifies Agent Onboarding, Enrollment, and Commissions

ConnectureDRX, the leading provider of Medicare shopping, quoting, and enrollment solutions, has announced a long-term strategic partnership withEvolveNXT, the premier provider of broker compensation and sales performance management software built specifically for the health insurance industry. https://mma.prnewswire.com/media/2693193/ConnectureDRX_EvolveNXT_Logo.jpg This collaboration brings together two industry-leading platforms to create a seamless, end-to-end experience for health plans, agencies, and

Bronstein, Gewirtz & Grossman, LLC Encourages Luna Innovations Incorporated (LUNA) Stockholders to Inquire about Securities Investigation

NEW YORK, NY / ACCESS Newswire / May 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Luna Innovations Incorporated ("Luna" or "the Company") (NASDAQ:LUNA). Investors who purchased Luna securities prior to May 16, 2022, and continue to hold to the present, are encouraged to obtain additional

Bronstein, Gewirtz & Grossman, LLC Is Investigating Cleveland-Cliffs Inc. (CLF) And Encourages Shareholders to Connect

NEW YORK CITY, NY / ACCESS Newswire / May 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cleveland-Cliffs Inc. ("Cleveland-Cliffs" or "the Company") (NYSE:CLF). Investors who purchased Cleveland-Cliffs securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/CLF. Investigation

Customers Bancorp, Inc. (CUBI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

NEW YORK, NY / ACCESS Newswire / May 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Customers Bancorp, Inc. ("Customers Bancorp" or "the Company") (NYSE:CUBI). Investors who purchased Customers Bancorp securities prior to March 1, 2024, and continue to hold to the present, are encouraged to

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Flowco Holdings Inc. (FLOC) And Encourages Investors to Reach Out

NEW YORK, NY / ACCESS Newswire / May 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Flowco Holdings Inc. ("Flowco" or "the Company") (NYSE:FLOC). Investors who purchased Flowco securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/FLOC. Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Myriad Genetics, Inc. (MYGN) Shareholders to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / May 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Myriad Genetics, Inc. ("Myriad Genetics, Inc." or "the Company") (NASDAQ:MYGN). Investors who purchased Myriad Genetics, Inc. securities are encouraged to obtain additional information and assist the investigation by visiting

Scroll to Top